A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128

Clinical trial NCT05354102 · UNKNOWN

Trial details

NCT number: NCT05354102
Sponsor: Biomica Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Melanoma Renal Cell Carcinoma

Start date: 2022-05-01
Primary completion: 2024-05-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.